Literature DB >> 23967394

Is routine replacement of i.v. administration sets required after each change of intermittently administrated antibiotic infusions?

Felix von Au1, Sylvia Ryll, Christian Wegner, Stephan Gessner, Axel Kramer.   

Abstract

AIM: Manufacturers' instructions recommend changing the infusion line together with the infusion bottle after each administration. We investigated if the complete infusion line may be microbiologically contaminated after short-time antibiotic and rinse-solution application.
METHOD: Immediately after the change of an infusion administration set after 72 hours the remaining antibiotic solution was inactivated with yolk and cultured on blood agar for 48 hours at 36°C to detect possible contaminants.
RESULTS: Among 87 investigated samples no microbial growth was detected. One sample which hadn't any contact to antibiotics yielded 1 colony forming unit (cfu) of coagulase-negative staphylococci. These results suggest that in case of consecutive antibiotic-short- and rinse-infusions the infusion line may be in place up to 72 hours without contamination. This, however, may be only the case for infusion sets, which are in contact with antibiotics. If no antibiotic is administered, the infusion bottle and the infusion line must be renewed together for every change. To clarify this question into more detail, a larger consecutive study is required.
CONCLUSION: I.v. administration sets without any contact to antibiotics must be changed together with their infusion bottle after administration. In case of consecutive antibiotic-short- and rinse-infusions our pilot study suggests using the i.v. administration sets for up to 72 hours without renewing it at every infusion-set exchange.

Entities:  

Keywords:  CVC; antibiotic-short-infusions; changing of infusion bottle change; changing of renew infusion

Year:  2013        PMID: 23967394      PMCID: PMC3746604          DOI: 10.3205/dgkh000208

Source DB:  PubMed          Journal:  GMS Hyg Infect Control        ISSN: 2196-5226


Introduction

Manufacturers’ instructions recommend changing the i.v. administration set together with the infusion bottle after each administration. The recommendation of KRINKO [1] requires similarly, that feed-lines in the case of short infusions must be discarded after the completion of the infusion. However, in practice it is observed in the case of several directly cascaded short infusions for a given drug compatibility usually the same administration line is used. Particularly in intensive care, a number of different solutions are administered over the limb of the central venous catheter (CVC) daily. Therefore, following the manufacturers’ recommendations is associated with costs and increased workload for healthcare workers. To the best of our knowledge no studies have investigated if immediate renewing of the complete i.v. administration set together with an emptied infusion bottle is required. Even the very comprehensive CDC's 2011 Guidelines for the prevention of intravascular catheter-related infections [2] leave this aspect unanswered and categorized it as unresolved issue. Therefore we investigated microbiologically if the complete infusion line may be contaminated after short-time antibiotic and rinse-solution applications. However the issue was limited to short infusions of antibiotics, which were infused over the same limb. A constant limb flow was ensured by intermediate rinse solutions.

Methods

The sample collection for the pilot study was performed at the 72-hourly CVS-system-change of the antibiotic short infusions from July 13, 2012 to August 7, 2012 at participating intensive care units. The detailed sequence of sampling is summarized in Table 1 (Tab. 1).
Table 1

Frequency of infusion bottle exchanges within 72 h

The i.v. administration sets together with the infusion bottles containing antibiotics and rinse solution (0.9% NaCl) closed with seals were packaged individually and aseptically and transported to the laboratory in a cool bag (4°C). Remaining fluid residuals were obtained aseptically from the inside lumen of i.v. administration sets inside a lamina-air-flow-bench. To inactivate the antimicrobial activity of antibiotics residues, samples were neutralized with yolk (1 part sample solutions – 9 parts yolk suspension) from hen eggs of bio-lifestock without antibiotic feeding. Immediately before the usage, the yolk was taken with a sterile syringe suspension and mixed in the ratio of 1:1 with aqua dest. in a sterile tube. The effectiveness of the neutralization was validated in previous in-vitro dilution tests. Approximately 15 minutes after adding the neutralizer, 0.1 mL of the solution was plated on blood agar and incubated for 48 hours at 36±1°C.

Results

Among 87 investigated samples no microbial growth was detected. One sample which hadn’t any contact to antibiotics yielded 1 colony forming unit (cfu) of coagulase-negative staphylococci (CoNS). Within 72 hours the exchanges of the bottles differed between 6 and 36, in average 18 exchange were performed (Table 1 (Tab. 1)). The results of our investigation suggest that i.v. administration sets which remain connected to infusion bottles (antibiotic short infusions and rinse solution) under a constant flow may be in place over duration of up to 72 hours without contamination. However for non-antibiotic flow we conclude that the i.v. administration set must be renewed at every change of an infusion bottle, because in the erroneously taken sample without any antibiotic-access 1 cfu CoNS was detected. CoNS can cause severe sepsis especially in neonates [3], [4], but they are also not harmless for adults [5], [6]. In order to interpret the results correctly it is important to note that the ICU staff who worked on the CVCs was not specifically instructed in the hygienic principles of changing an infusion bottle before the start of the pilot study. This should prevent the known effect of the training on the suppression of the central-line associated infections [7], [8], [9].

Conclusion

I.v. administration sets without any contact to antibiotics must be changed together with their infusion bottle after administration. In case of consecutive antibiotic-short- and rinse-infusions our pilot study suggests using the i.v. administration sets for up to 72 hours without renewing it at every infusion-set exchange. However, to clarify this question into more detail, a larger consecutive study is required.

Notes

Competing interests

The study was sponsored by BBraun AG Melsungen, Germany.
  9 in total

Review 1.  Prevention and management of central line-associated bloodstream infections in hospital practice.

Authors:  Stephen Y Liang; Hani Khair; Michael J Durkin; Jonas Marschall
Journal:  Hosp Pract (1995)       Date:  2012-02

2.  Coagulase-negative staphylococcal skin carriage among neonatal intensive care unit personnel: from population to infection.

Authors:  Vishal Hira; Marcel Sluijter; Wil H F Goessens; Alewijn Ott; Ronald de Groot; Peter W M Hermans; René F Kornelisse
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

3.  Determining the significance of coagulase-negative staphylococci identified in cultures of paired blood specimens from neonates by species identification and strain clonality.

Authors:  Yhu-Chering Huang; Ying-Hsiang Wang; Lin-Hui Su; Yi-Hong Chou; Rey-In Lien; Tzou-Yien Lin
Journal:  Infect Control Hosp Epidemiol       Date:  2006-01-06       Impact factor: 3.254

4.  Zeroing in on zero tolerance for central line-associated bacteremia.

Authors:  Jeanne Zack
Journal:  Am J Infect Control       Date:  2008-12       Impact factor: 2.918

5.  Guidelines for the prevention of intravascular catheter-related infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Am J Infect Control       Date:  2011-05       Impact factor: 2.918

6.  A collaborative, systems-level approach to eliminating healthcare-associated MRSA, central-line-associated bloodstream infections, ventilator-associated pneumonia, and respiratory virus infections.

Authors:  Donna M Henderson; Thomas O Staiger; Gene N Peterson; Mika N Sinanan; Cindy L Angiulo; Vanessa A Makarewicz; Lorie M Wild; Estella E Whimbey
Journal:  J Healthc Qual       Date:  2012-08-03       Impact factor: 1.095

7.  Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective.

Authors:  D G Maki; J T Botticelli; M L LeRoy; T S Thielke
Journal:  JAMA       Date:  1987-10-02       Impact factor: 56.272

8.  Conventional and molecular characterization of coagulase-negative staphylococcus in hospital isolates.

Authors:  Poonam Sharma; Kunal K Lahiri; Ketoki Kapila
Journal:  Indian J Pathol Microbiol       Date:  2011 Jan-Mar       Impact factor: 0.740

9.  [Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment].

Authors:  A Fernández-Rufete; E García-Vázquez; A Hernández-Torres; M Canteras; J Ruiz; J Gómez
Journal:  Rev Esp Quimioter       Date:  2012-09       Impact factor: 1.553

  9 in total
  1 in total

1.  GMS Hygiene and Infection Control.

Authors:  Axel Kramer; Ojan Assadian; Wolfgang Kohnen
Journal:  GMS Hyg Infect Control       Date:  2013-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.